Tzianabos Arthur Insider Trades

Insider Trading History

Track insider trading activity for Tzianabos Arthur. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Stoke Therapeutics
Stoke Therapeutics STOK
Interim Executive Chair
Holding Value $944k 31,339 shares
Last Trade
Mar 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$174k 4,355 shares
$40.00
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Interim Executive Chair
Holding Value $1.08M 35,694 shares
Last Trade
Mar 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$152k 3,955 shares
$38.35
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Interim Executive Chair
Holding Value $3.58M 118,696 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$152k 3,955 shares
$38.35
$30.12
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $749k 53,521 shares
Last Trade
Oct 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 53,521 shares
$2.80
$14.00
Stoke Therapeutics
Stoke Therapeutics STOK
Interim Executive Chair
Holding Value $3.69M 122,651 shares
Last Trade
Mar 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 122,651 shares
$8.33
$30.12
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$97.6k 38,441 shares
$2.54
$14.00
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $359k 25,674 shares
Last Trade
Feb 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.6k 38,441 shares
$2.54
$14.00
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $230k 7,639 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 7,639 shares
$16.41
$30.12
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $115k 8,248 shares
Last Trade
Mar 25, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.02k 1,095 shares
$0.93
$14.00
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $179k 12,767 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9k 12,767 shares
$0.93
$14.00
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $112k 7,983 shares
Last Trade
Mar 25, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$248 265 shares
$0.93
$14.00
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $0 0 shares
Last Trade
Mar 25, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.02k 1,095 shares
$0.93
$14.00
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $0 0 shares
Last Trade
Feb 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$131k 31,739 shares
$4.12
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $956k 31,739 shares
Last Trade
Feb 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$131k 31,739 shares
$4.12
$30.12
Homology Medicines
Homology Medicines FIXX
Director
Holding Value $120k 128,778 shares
Last Trade
Jan 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.58k 13,037 shares
$0.66
$0.93
Homology Medicines
Homology Medicines FIXX
Director
Holding Value $21.5k 23,000 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.7k 23,000 shares
$1.03
$0.93
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $586k 19,441 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 19,441 shares
$12.46
$30.12
Homology Medicines
Homology Medicines FIXX
Director
Holding Value $101k 108,395 shares
Last Trade
Jan 09, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.5k 10,616 shares
$1.65
$0.93
Akouos
Akouos AKUS
Director
Holding Value $0 0 shares
Last Trade
Dec 01, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$213k 16,000 shares
$13.29
$13.29
Akouos
Akouos AKUS
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$358k 26,930 shares
$13.29
$13.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up